Workflow
Kidney Disease Therapy
icon
搜索文档
ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy
Seeking Alpha· 2025-09-19 14:52
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?The last time I covered ProKidney (NASDAQ: PROK ), the Winston-Salem, North Carolina based biotech, for Seeking Alpha, it was July, and its share price was skyrocketing, jumping from $0.6, to >$4.5 overnight, after ...